{
    "root": "359e91ba-a244-6357-e063-6394a90a9542",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "GABAPENTIN",
    "value": "20250521",
    "ingredients": [
        {
            "name": "MANNITOL",
            "code": "3OWL53L36A"
        },
        {
            "name": "HYDROXYPROPYL CELLULOSE, UNSPECIFIED",
            "code": "9XZ8H6N6OH"
        },
        {
            "name": "CROSPOVIDONE",
            "code": "2S7830E561"
        },
        {
            "name": "TALC",
            "code": "7SEV7J4R1U"
        },
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4"
        },
        {
            "name": "GLYCERYL DIBEHENATE",
            "code": "R8WTH25YS2"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "GABAPENTIN",
            "code": "6CW7F3G59X"
        }
    ],
    "indications": "Gabapentin tablets are indicated for:\n                  \n                     Management of postherpetic neuralgia in adults\n                     Adjunctive therapy in the treatment of partial onset seizures, with and without secondary generalization, in adults and pediatric patients 3 years and older with epilepsy",
    "contraindications": "Postherpetic Neuralgia (2.1) Dose can be titrated up as needed to a dose of 1800 mg/day Day 1: Single 300 mg dose Day 2: 600 mg/day (i.e., 300 mg two times a day) Day 3: 900 mg/day (i.e., 300 mg three times a day) Epilepsy with Partial Onset Seizures (2.2) Patients 12 years of age and older: starting dose is 300 mg three times daily; may be titrated up to 600 mg three times daily Patients 3 to 11 years of age: starting dose range is 10 to 15 mg/kg/day, given in three divided doses; recommended dose in patients 3 to 4 years of age is 40 mg/kg/day, given in three divided doses; the recommended dose in patients 5 to 11 years of age is 25 to 35 mg/kg/day, given in three divided doses. The recommended dose is reached by upward titration over a period of approximately 3 days Dose should be adjusted in patients with reduced renal function (2.3, 2.4)",
    "warningsAndPrecautions": "Gabapentin tablets, USP are supplied as follows:\n                  \n                  \n                  600 mg tablets:\n                  \n                  \n                  White colored film coated, Oval Shaped, biconvex tablets de-bossed with ‘T’on the left side of the bisect and ‘1’on the right side of the bisect on one side and bisect on other side; supplied in\n                  \n                  \n                  Bottles of 30: NDC 76420-836-30 (repackaged from NDC 31722-166-xx)\n                  Bottles of 60: NDC 76420-836-60 (repackaged from NDC 31722-166-xx)\n                  Bottles of 90: NDC 76420-836-90 (repackaged from NDC 31722-166-xx)\n                  Bottles of 100: NDC 76420-836-01 (relabeled from NDC 31722-166-01)\n                  Bottles of 120: NDC 76420-836-12 (repackaged from NDC 31722-166-xx)\n                  Bottles of 500: NDC 76420-836-05 (relabeled from NDC 31722-166-05)\n                  \n                  \n                  800 mg tablets:\n                  \n                  \n                  White colored film coated, Oval Shaped, biconvex tablets de-bossed with ‘T’on the left side of the bisect and ‘3’on the right side of the bisect on one side and bisect on other side; supplied in\n                  \n                  \n                  Bottles of 30: NDC 76420-837-30 (repackaged from NDC 31722-167-xx)\n                  Bottles of 60: NDC 76420-837-60 (repackaged from NDC 31722-167-xx)\n                  Bottles of 90: NDC 76420-837-90 (repackaged from NDC 31722-167-xx)\n                  Bottles of 100: NDC 76420-837-01 (relabeled from NDC 31722-167-01)\n                  Bottles of 500: NDC 76420-837-05 (relabeled from NDC 31722-167-05)\n                  \n                  \n                  Store gabapentin tablets at 25°C (77°F); excursions permitted between 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature].",
    "adverseReactions": "Gabapentin tablets are contraindicated in patients who have demonstrated hypersensitivity to the drug or its ingredients."
}